Eravacycline Proves Non-Inferior to Meropenem for the Treatment of cIAI in IGNITE4 Trial
May 4th 2018Data from the IGNITE4 phase 3 trial supports the use of eravacycline for the treatment of complicated intra-abdominal infections (cIAI), including infections caused by pathogens resistant to other antibiotics.
Read More
Exploring the Best Treatment Option for Initial C. diff Infection In Pediatric Patients
April 20th 2018Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.
Read More